(Q45963541)

18 December 2017

title

Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2. (English)

1 reference

18 December 2017

author

Gerjon Hannink

1

1 reference

18 December 2017

Willeke F Daamen

3

1 reference

18 December 2017

author name string

Paul J Geutjes

2

1 reference

18 December 2017

Pieter Buma

4

1 reference

18 December 2017

publication date

8 November 2012

1 reference

18 December 2017

Journal of Materials Science: Materials in Medicine

published in

1 reference

18 December 2017

volume

24

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

325-332

1 reference

18 December 2017

Biphasic calcium phosphate bioceramics: preparation, properties and applications

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Bioresorbability, porosity and mechanical strength of bone substitutes: what is optimal for bone regeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Three-dimensional technology and bone morphogenetic protein in frontal bone reconstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Delivery systems for bone growth factors - the new players in skeletal regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Binding and release of basic fibroblast growth factor from heparinized collagen matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Loading of collagen-heparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Interaction of heparin with human basic fibroblast growth factor: protection of the angiogenic protein from proteolytic degradation by a glycosaminoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

The use of heparan sulfate to augment fracture repair in a rat fracture model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Hyaluronate-heparin conjugate gels for the delivery of basic fibroblast growth factor (FGF-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

The importance of drug delivery to optimize the effects of bone morphogenetic proteins during periodontal regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

No negative effects of bone impaction grafting with bone and ceramic mixtures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Next generation calcium phosphate-based biomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Osteoblast interactions with calcium phosphate ceramics modified by coating with type I collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10856-012-4802-4

Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects

21 January 2018

1 reference

12 December 2020

Healing of segmental bone defects with granular porous hydroxyapatite augmented with recombinant human osteogenic protein-1 or autologous bone marrow

1 reference

12 December 2020

Heparan-like molecules induce the repair of skull defects

1 reference

12 December 2020

Carrier systems for bone morphogenetic proteins

1 reference

12 December 2020

Heparin protects basic and acidic FGF from inactivation

1 reference

12 December 2020

Evaluation of Collagen Crosslinking Techniques

1 reference

12 December 2020

Properties of osteoconductive biomaterials: calcium phosphates.

1 reference

12 December 2020

Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2

1 reference

12 December 2020

Preparation and characterization of porous crosslinked collagneous matrices containing bioavailable chondroitin sulfate

1 reference

12 December 2020

What should be the characteristics of the ideal bone graft substitute?

1 reference

12 December 2020

Injectable bone-graft substitutes: current products, their characteristics and indications, and new developments

1 reference

12 December 2020

10.1007/S10856-012-4802-4

Identifiers

DOI

1 reference

18 December 2017

Dimensions Publication ID

1003089700

0 references

1 reference

18 December 2017